Eurizon Capital SGR S.p.A. Purchases Shares of 68,093 HCA Healthcare, Inc. $HCA

Eurizon Capital SGR S.p.A. purchased a new stake in shares of HCA Healthcare, Inc. (NYSE:HCA) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 68,093 shares of the company’s stock, valued at approximately $31,801,000.

A number of other hedge funds have also recently made changes to their positions in the business. Hillsdale Investment Management Inc. bought a new position in shares of HCA Healthcare in the fourth quarter worth about $976,000. Triglav Investments D.O.O. boosted its stake in shares of HCA Healthcare by 7.4% in the fourth quarter. Triglav Investments D.O.O. now owns 2,148 shares of the company’s stock worth $1,003,000 after acquiring an additional 148 shares during the period. Fideuram Asset Management Ireland dac bought a new position in shares of HCA Healthcare in the fourth quarter worth about $1,551,000. Principia Wealth Advisory LLC boosted its stake in shares of HCA Healthcare by 2,900.0% in the fourth quarter. Principia Wealth Advisory LLC now owns 210 shares of the company’s stock worth $98,000 after acquiring an additional 203 shares during the period. Finally, Basepoint Wealth LLC bought a new position in shares of HCA Healthcare in the fourth quarter worth about $35,000. Institutional investors own 62.73% of the company’s stock.

HCA Healthcare Price Performance

Shares of HCA stock opened at $377.72 on Friday. HCA Healthcare, Inc. has a 1 year low of $330.00 and a 1 year high of $556.52. The stock’s 50 day simple moving average is $451.94 and its two-hundred day simple moving average is $480.74. The company has a market cap of $83.79 billion, a PE ratio of 12.99, a price-to-earnings-growth ratio of 1.20 and a beta of 1.18.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings data on Friday, April 24th. The company reported $7.15 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $7.19 by ($0.04). HCA Healthcare had a net margin of 8.89% and a negative return on equity of 295.93%. The company had revenue of $19.11 billion for the quarter, compared to analysts’ expectations of $19.09 billion. During the same quarter last year, the company earned $6.45 earnings per share. The company’s revenue for the quarter was up 4.3% on a year-over-year basis. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. Equities research analysts expect that HCA Healthcare, Inc. will post 30.07 EPS for the current year.

HCA Healthcare Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, June 30th. Stockholders of record on Tuesday, June 16th will be issued a $0.78 dividend. This represents a $3.12 annualized dividend and a dividend yield of 0.8%. The ex-dividend date is Tuesday, June 16th. HCA Healthcare’s dividend payout ratio is presently 10.73%.

Analyst Upgrades and Downgrades

A number of equities research analysts recently commented on the company. Stephens decreased their target price on HCA Healthcare from $560.00 to $530.00 and set an “overweight” rating on the stock in a research report on Monday, April 27th. JPMorgan Chase & Co. decreased their target price on HCA Healthcare from $535.00 to $490.00 and set a “neutral” rating on the stock in a research report on Tuesday, May 19th. Barclays decreased their target price on HCA Healthcare from $551.00 to $496.00 and set an “overweight” rating on the stock in a research report on Monday, April 27th. Sanford C. Bernstein decreased their target price on HCA Healthcare from $541.00 to $503.00 and set a “market perform” rating on the stock in a research report on Tuesday, April 28th. Finally, Mizuho upped their price objective on HCA Healthcare from $540.00 to $585.00 and gave the company an “outperform” rating in a research report on Wednesday, February 25th. Sixteen investment analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $515.77.

About HCA Healthcare

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.